Результаты поиска - Ming‐Lung Yu

Отмена результатов
  1. 1
    Treatment of chronic hepatitis C in Asia: When East meets West

    Treatment of chronic hepatitis C in Asia: When East meets West по Ming‐Lung Yu, Wan‐Long Chuang

    Опубликовано 2009
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  2. 2
    Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy

    Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy по Chung‐Feng Huang, Ming‐Lung Yu

    Опубликовано 2020
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  3. 3
    Reply to the comment on “High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C”

    Reply to the comment on “High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C” по Yen‐Chun Chen, Ming‐Lung Yu

    Опубликовано 2025
    Полный текст
    Carta
    Добавить в Избранное
    Сохранить в:
  4. 4
    Hepatitis B reactivation during or after direct acting antiviral therapy – implication for susceptible individuals

    Hepatitis B reactivation during or after direct acting antiviral therapy – implication for susceptible individuals по Jacinta A. Holmes, Ming‐Lung Yu, Raymond T. Chung

    Опубликовано 2017
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  5. 5
    Unexpected early tumor recurrence in patients with hepatitis C virus-related hepatocellular carcinoma undergoing interferon-free therapy: Issue of the interval between HCC treatment and antiviral therapy

    Unexpected early tumor recurrence in patients with hepatitis C virus-related hepatocellular carcinoma undergoing interferon-free therapy: Issue of the interval between HCC treatmen... по Pei‐Chien Tsai, Chung‐Feng Huang, Ming‐Lung Yu

    Опубликовано 2016
    Полный текст
    Carta
    Добавить в Избранное
    Сохранить в:
  6. 6
    Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication

    Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication по Chung‐Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming‐Lung Yu

    Опубликовано 2024
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  7. 7
    MAFLD: an ideal framework for understanding disease phenotype in individuals of normal weight

    MAFLD: an ideal framework for understanding disease phenotype in individuals of normal weight по Ziyan Pan, Maryam Al Khatry, Ming‐Lung Yu, Ashok Choudhury, Giada Sebastiani, Saleh A. Alqahtani, Mohammed Eslam

    Опубликовано 2024
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  8. 8
    IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population

    IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population по Qiong Huang, Ji‐Ye Yin, Xingping Dai, Qi Pei, Min Dong, Zhiguang Zhou, Xi Huang, Ming‐Lung Yu, Hong‐Hao Zhou, Zhaoqian Liu

    Опубликовано 2010
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  9. 9
    Hepatitis C Virus Infection Increases Risk of Developing End-Stage Renal Disease Using Competing Risk Analysis

    Hepatitis C Virus Infection Increases Risk of Developing End-Stage Renal Disease Using Competing Risk Analysis по Jia‐Jung Lee, Ming‐Yen Lin, Jung‐San Chang, Chi‐Chih Hung, Jer‐Ming Chang, Hung‐Chun Chen, Ming‐Lung Yu, Shang‐Jyh Hwang

    Опубликовано 2014
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  10. 10
    Differentiation-Dependent Interactions between RUNX-1 and FLI-1 during Megakaryocyte Development

    Differentiation-Dependent Interactions between RUNX-1 and FLI-1 during Megakaryocyte Development по Hui Huang, Ming‐Lung Yu, Thomas E. Akie, Tyler B. Moran, Andrew J. Woo, Nathan Tu, Zachary Waldon, Yin Lin, Hanno Steen, Alan Cantor

    Опубликовано 2009
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  11. 11
    Systematic review with meta‐analysis: extrahepatic manifestations in chronic hepatitis C virus‐infected patients in East Asia

    Systematic review with meta‐analysis: extrahepatic manifestations in chronic hepatitis C virus‐infected patients in East Asia по Zobair M. Younossi, Linda Henry, Janus P. Ong, Atsushi Tanaka, Yuichiro Eguchi, Masashi Mizokami, Young‐Suk Lim, Yock Young Dan, Ming‐Lung Yu, Maria Stepanova

    Опубликовано 2019
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  12. 12
    Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C

    Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C по Hsieh Mc, Ming‐Lung Yu, Wan‐Long Chuang, SJ Shin, CY Dai, Shuo Chen, Z-Y. Lin, MY Hsieh, JF Liu, Ling‐Yu Wang, Chang Wy

    Опубликовано 2000
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  13. 13
    The impact of hepatitis C virus outside the liver: Evidence from Asia

    The impact of hepatitis C virus outside the liver: Evidence from Asia по Zobair M. Younossi, Atsushi Tanaka, Yuichiro Eguchi, Young‐Suk Lim, Ming‐Lung Yu, Norifumi Kawada, Yock Young Dan, C. Brooks-Rooney, Francesco Negro, Mario U. Mondelli

    Опубликовано 2016
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  14. 14
    Viral Interaction and Responses in Chronic Hepatitis C and B Coinfected Patients with Interferon-Alpha plus Ribavirin Combination Therapy

    Viral Interaction and Responses in Chronic Hepatitis C and B Coinfected Patients with Interferon-Alpha plus Ribavirin Combination Therapy по Wan‐Long Chuang, Chia‐Yen Dai, Wen‐Yu Chang, Li‐Po Lee, Zu‐Yau Lin, Shinn‐Cherng Chen, Ming‐Yuh Hsieh, Liang‐Yen Wang, Ming‐Lung Yu

    Опубликовано 2005
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  15. 15
    The first case of monkeypox virus infection detected in Taiwan: awareness and preparation

    The first case of monkeypox virus infection detected in Taiwan: awareness and preparation по Zih‐Syuan Yang, C. C. Lin, Aspiro Nayim Urbina, Wen‐Hung Wang, Wanchai Assavalapsakul, Sung‐Pin Tseng, Po‐Liang Lu, Yen‐Hsu Chen, Ming‐Lung Yu, Sheng‐Fan Wang

    Опубликовано 2022
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  16. 16
    Significant correlations between severe fatty liver and risk factors for metabolic syndrome

    Significant correlations between severe fatty liver and risk factors for metabolic syndrome по Pi‐Jung Hsiao, Kung‐Kai Kuo, Shyi–Jang Shin, Yi‐Hsin Yang, Wen‐Yi Lin, Jeng‐Fu Yang, Chao‐Chin Chiu, Wan‐Long Chuang, Tong‐Rong Tsai, Ming‐Lung Yu

    Опубликовано 2006
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  17. 17
    Association of Dialysis with the Risks of Cancers

    Association of Dialysis with the Risks of Cancers по Ming‐Yen Lin, Mei Chuan Kuo, Chi-Chih Hung, Wen‐Jeng Wu, Li Tzong Chen, Ming‐Lung Yu, Chih‐Cheng Hsu, Chien‐Hung Lee, Hung‐Chun Chen, Shang‐Jyh Hwang

    Опубликовано 2015
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  18. 18
    Diagnostic Value of Immunoglobulin G (IgG) and IgM Anti-Hepatitis E Virus (HEV) Tests Based on HEV RNA in an Area Where Hepatitis E Is Not Endemic

    Diagnostic Value of Immunoglobulin G (IgG) and IgM Anti-Hepatitis E Virus (HEV) Tests Based on HEV RNA in an Area Where Hepatitis E Is Not Endemic по Chen‐Chun Lin, Jaw‐Ching Wu, Ting‐Tsung Chang, Wen‐Yu Chang, Ming‐Lung Yu, Albert W. Tam, Shen-Chin Wang, Yi‐Hsiang Huang, Full‐Young Chang, Shou‐Dong Lee

    Опубликовано 2000
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  19. 19
    A Sustained Virological Response to Interferon or Interferon/Ribavirin Reduces Hepatocellular Carcinoma and Improves Survival in Chronic Hepatitis C: A Nationwide, Multicentre Study in Taiwan

    A Sustained Virological Response to Interferon or Interferon/Ribavirin Reduces Hepatocellular Carcinoma and Improves Survival in Chronic Hepatitis C: A Nationwide, Multicentre Stud... по Ming‐Lung Yu, Shi‐Ming Lin, Wan‐Long Chuang, Chia‐Yen Dai, Jing‐Houng Wang, Sheng‐Nan Lu, I‐Shyan Sheen, Wen‐Yu Chang, Chuan–Mo Lee, Yun–Fan Liaw

    Опубликовано 2006
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  20. 20
    Impact of tumor size on the prognosis of hepatocellular carcinoma in patients who underwent liver resection

    Impact of tumor size on the prognosis of hepatocellular carcinoma in patients who underwent liver resection по Chia‐Yen Dai, Ching‐Yeh Lin, Pei‐Chien Tsai, Ping‐Yi Lin, Ming‐Lun Yeh, Chung‐Feng Huang, Wen‐Tsan Chang, Jee‐Fu Huang, Ming‐Lung Yu, Yao‐Li Chen

    Опубликовано 2017
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: